Your session is about to expire
← Back to Search
Web-Based Tool for Low-Risk Prostate Cancer
N/A
Waitlist Available
Led By Archana Radhakrishnan
Research Sponsored by University of Michigan Rogel Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 9 months post last patient recruitment
Awards & highlights
Study Summary
This trial tests a patient-centered intervention to improve low-risk cancer care by engaging PCPs. Results will inform a larger trial to maximize patient adherence.
Who is the study for?
This trial is for men aged 55 or older with low-risk prostate cancer who are currently on active surveillance. Participants must have a primary care provider, internet access, and the ability to use it. They should be able to read/speak English and make decisions independently (no dementia/memory loss).Check my eligibility
What is being tested?
The study tests a patient-centered web-based tool called MAP, designed to help healthcare providers support men under active surveillance for prostate cancer. The goal is to improve adherence and management of low-risk cases by engaging Primary Care Physicians in care.See study design
What are the potential side effects?
Since this trial involves the use of an informational website rather than medication, traditional side effects are not applicable. However, participants may experience stress or anxiety related to monitoring their health condition through the platform.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 9 months post last patient recruitment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 9 months post last patient recruitment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability - Mean Satisfaction Scores
Feasibility - Uptake
Feasibility - recruitment
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention websiteExperimental Treatment1 Intervention
Group II: Control MUSIC websiteActive Control1 Intervention
This is usual care and all urologists are encouraged to refer their patients to the patient educational materials on the MUSIC website (http://www.musicurology.com/patientmaterials/).
Find a Location
Who is running the clinical trial?
University of Michigan Rogel Cancer CenterLead Sponsor
294 Previous Clinical Trials
24,224 Total Patients Enrolled
28 Trials studying Prostate Cancer
2,946 Patients Enrolled for Prostate Cancer
National Cancer Institute (NCI)NIH
13,703 Previous Clinical Trials
40,931,710 Total Patients Enrolled
563 Trials studying Prostate Cancer
509,024 Patients Enrolled for Prostate Cancer
Archana RadhakrishnanPrincipal InvestigatorUniversity of Michigan Rogel Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 55 years old or older.I am a man with low-risk prostate cancer and am being actively monitored.I am a man with a primary care doctor.I have named my primary care provider in the baseline survey.I am a man who cannot read or speak English.I am a man with dementia or significant memory loss affecting my decision-making.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention website
- Group 2: Control MUSIC website
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment available for this research study at present?
"Affirmative. According to clinicaltrials.gov, the trial posted on November 9th 2022 is still recruiting participants across a single medical centre; so far 40 patients have been accepted into this study."
Answered by AI
How many individuals are partaking in this investigation?
"Affirmative. The information provided on clinicaltrials.gov indicates that this research is actively recruiting participants. It was initially posted on November 9th 2022 and its most recent update occurred February 28th 2023. 40 patients are needed to be enrolled from a single location for the study's completion."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger